NCT03272711View on ClinicalTrials.gov

Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training

PHASE4CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 24, 2019

Study Completion Date

January 24, 2019

Conditions
Age-related Cognitive Decline
Interventions
DRUG

Vortioxetine 10 mg

BEHAVIORAL

Cognitive training program

Online training program, 30 minutes a day, 5 times a week

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
lead

Washington University School of Medicine

OTHER

collaborator

Queen's University

OTHER

collaborator

Takeda

INDUSTRY